Androgen Excess Polycystic Ovary Syndrome Society Meeting
雄激素过多多囊卵巢综合症学会会议
基本信息
- 批准号:10237711
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-15 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:Acanthosis NigricansAcneAddressAdrenal GlandsAdvisory CommitteesAffectAgingAmericanAndrogensAnxiety DisordersAreaAwardAwarenessBasic ScienceBlood VesselsCardiovascular DiseasesCaringChild CareChildhoodClinicalClinical ResearchClinical Trials DesignCollaborationsCommunitiesCritiquesDefectDetectionDevelopmentDiabetes MellitusDiagnosisDisciplineDiscipline of obstetricsDiseaseDyslipidemiasEducationEmbryologyEndocrineEndometrial CarcinomaEpidemiologistEpidemiologyEthnic OriginEtiologyEuropeanEvaluationFemaleFosteringFutureGeneral PopulationGeneticGenotypeGoalsGrantGuidelinesGynecologicGynecologyHealthHirsutismHumanHyperandrogenismHypertensionInfertilityInsulinInsulin ResistanceInternal MedicineInternationalInvestigationKnowledgeLocationMale Pattern BaldnessMedicalMenopauseMetabolicMetabolic syndromeMolecularMolecular GeneticsMood DisordersMorbidity - disease rateNeoplasmsNeurosecretory SystemsNon-Insulin-Dependent Diabetes MellitusNutritionistOralOvarianParticipantPatientsPharmaceutical PreparationsPhenotypePhysiciansPolycystic Ovary SyndromePopulationPositioning AttributePreventionProfessional OrganizationsPrognosisPsychologistPublicationsQuality of lifeRaceReportingReproductionReproductive EndocrinologyReproductive MedicineRequest for ApplicationsResearchResearch PersonnelRisk FactorsScientistSenior ScientistSleep Apnea SyndromesSocietiesSupport GroupsSurveysSyndromeTranslatingTravelUnderrepresented MinorityUpdateWomanWorkadrenal hyperplasiaclinical applicationclinical carecollegediabetogenicdisorder preventionimprovedinterestlecturesmedical complicationmeeting abstractsmeetingsmultidisciplinarynext generationobesity riskposterspremature adrenarcheprofessorprogramspsychosocialreproductivesymposiumtreatment strategy
项目摘要
Project Summary/Abstract
The meetings of the Androgen Excess-Polycystic Ovary Syndrome (AE-PCOS) Society are the only ones that
convene the world's largest group of researchers and clinicians specifically focused on androgen-excess
related disorders. Both the Annual and Update meetings bring together diverse participants to discuss their
latest research findings, to encourage future research collaborations and to disseminate relevant and accurate
health information to the clinical community and general public. The attendees represent several regions of the
world and a variety of disciplines including medical, pediatric and reproductive endocrinology, gynecology,
internal medicine, psychologists, epidemiologists, clinical nutritionists and physiologists. The two-day Annual
Meeting has a well-established format consisting of multiple sessions that include invited scientific lectures,
oral and poster presentations, meet-the-professor sessions, all with interactive and/or question and answer
opportunities. We provide travel awards for junior investigators and child care awards to encourage the
participation of the next generation of researchers and clinicians. The one-day Update Meetings, also held
annually, are focused on basic science research and have a specific theme. We have demonstrated
participation by females and underrepresented minorities in our meetings, membership and Board of Directors.
One of the new highlights is increased collaboration with patient support groups and actively engaging patients
and consumers in our meetings. The Society is composed of basic and clinical scientists and clinicians whose
major interest is the etiology, diagnosis, and treatment of androgen excess disorders. The AE-PCOS Society
has successfully organized 17 Annual Meetings, 4 Update Meetings which are organized as satellite meetings
along with the ASRM and Endocrine Society meetings in the USA or stand alone in other international
locations. The Society through its meetings and resultant publications (14 guidelines and position statements)
has had significant impact on dvelopment of criteria for diagnosis, management and treatment strategies for
PCOS.
项目总结/摘要
雄激素过多-多囊卵巢综合征(AE-PCOS)协会的会议是唯一一个
召集世界上最大的研究人员和临床医生小组,专门关注雄激素过量
相关疾病。年度会议和最新会议都汇集了不同的参与者,讨论他们的
最新的研究成果,以鼓励未来的研究合作,并传播相关的和准确的
向临床社区和公众提供健康信息。与会者代表了几个地区的
世界和各种学科,包括医学,儿科和生殖内分泌学,妇科,
内科医生、心理学家、流行病学家、临床营养学家和生理学家。为期两天的年度
会议有一个完善的格式,包括多个会议,包括邀请科学讲座,
口头和海报介绍,会见教授会议,所有互动和/或问答
机会我们为初级调查人员提供旅行奖励和儿童保育奖励,以鼓励
下一代研究人员和临床医生的参与。还举行了为期一天的最新情况介绍会,
每年都有一个特定的主题,侧重于基础科学研究。我们已经证明
女性和代表性不足的少数族裔参与我们的会议、成员和董事会。
其中一个新的亮点是增加与患者支持团体的合作,并积极吸引患者
消费者在我们的会议。该协会由基础和临床科学家和临床医生组成,
主要兴趣是雄激素过多症的病因、诊断和治疗。AE-PCOS协会
已成功组织了17次年会,4次更新会议,这些会议是作为卫星会议组织的
沿着美国的ASRM和内分泌学会会议,或单独参加其他国际会议。
地点学会通过其会议和出版物(14项准则和立场声明)
对诊断、管理和治疗策略标准的发展产生了重大影响。
PCOS。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANUJA DOKRAS其他文献
ANUJA DOKRAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANUJA DOKRAS', 18)}}的其他基金
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
- 批准号:
10431620 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
- 批准号:
10616771 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome
COMET-PCOS 试验 - 比较口服避孕药与二甲双胍在超重/肥胖多囊卵巢综合症女性医疗管理中的效果
- 批准号:
9286789 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome
COMET-PCOS 试验 - 比较口服避孕药与二甲双胍在超重/肥胖多囊卵巢综合症女性医疗管理中的效果
- 批准号:
9924273 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome
COMET-PCOS 试验 - 比较口服避孕药与二甲双胍在超重/肥胖多囊卵巢综合症女性医疗管理中的效果
- 批准号:
10155513 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
Androgen Excess Polycystic Ovary Syndrome Society Meeting
雄激素过多多囊卵巢综合症学会会议
- 批准号:
10613338 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
Androgen Excess Polycystic Ovary Syndrome Society Meeting
雄激素过多多囊卵巢综合症学会会议
- 批准号:
10378739 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
DIAGNOSTIC MARKERS FOR EARLY DETECTION AND TREATMENT OF PRETERM PREGNANCIES
早孕早期检测和治疗的诊断标志物
- 批准号:
7604876 - 财政年份:2007
- 资助金额:
$ 1万 - 项目类别:
相似海外基金
Metagenomic discovery and optimization of novel endolysins targeting Cutibacterium acnes to treat acne vulgaris
针对痤疮皮肤杆菌治疗寻常痤疮的新型内溶素的宏基因组发现和优化
- 批准号:
10821291 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Selective CYP26 inhibitors for the oral treatment of recalcitrant nodular acne.
用于口服治疗顽固性结节性痤疮的选择性 CYP26 抑制剂。
- 批准号:
10822482 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
ENLIGHT : Light-sensitive Engineered Living Material for acne therapy
ENLIGHT:用于痤疮治疗的光敏工程活性材料
- 批准号:
EP/Y03029X/1 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Fellowship
Developing a novel medical-grade microneedle patch to treat acne vulgaris
开发一种新型医用级微针贴片来治疗寻常痤疮
- 批准号:
10053162 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Collaborative R&D
Smart Photodynamic Therapy for Acne by Reversibly Switchable Intersystem Crossing in Pure Organic Materials
通过纯有机材料中的可逆可切换系间交叉来治疗痤疮的智能光动力疗法
- 批准号:
10483461 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris
寻常痤疮中 Th17 细胞外陷阱介导的抗菌宿主防御
- 批准号:
10502200 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris
寻常痤疮中 Th17 细胞外陷阱介导的抗菌宿主防御
- 批准号:
10698121 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Acne: a disease of lipid metabolism, microbiome and the immune response
痤疮:一种脂质代谢、微生物组和免疫反应疾病
- 批准号:
10404440 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Acne: a disease of lipid metabolism, microbiome and the immune response
痤疮:一种脂质代谢、微生物组和免疫反应疾病
- 批准号:
10404436 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
- 批准号:
10296086 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:














{{item.name}}会员




